| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10641955.2011.638956 |
| P698 | PubMed publication ID | 22148978 |
| P50 | author | André Scherag | Q29999935 |
| P2093 | author name string | Markus Schmidt | |
| Rainer Kimmig | |||
| Karla Drommelschmidt | |||
| Barbara Mikat | |||
| Anna Zeller | |||
| P2860 | cites work | The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A | Q22009032 |
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation | Q33664901 | ||
| The human placental bed revisited | Q34934408 | ||
| Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia | Q36288766 | ||
| Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review | Q37665733 | ||
| Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies | Q43991495 | ||
| Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity | Q46462668 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy | Q47889999 | ||
| Placental growth factor: a predictive marker for preeclampsia? | Q51734601 | ||
| Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. | Q51914188 | ||
| First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia | Q56619507 | ||
| Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction | Q57316937 | ||
| P433 | issue | 2 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| P304 | page(s) | 261-267 | |
| P577 | publication date | 2011-12-09 | |
| P1433 | published in | Hypertension in Pregnancy | Q5958696 |
| P1476 | title | βhCG and PAPP-A in First Trimester: Predictive Factors for Preeclampsia? | |
| P478 | volume | 31 |
| Q91694547 | Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study |
| Q47095790 | Correlation of hypertensive disorders in pregnancy with procedures of in vitro fertilization and pregnancy outcomes |
| Q36125098 | Early detection of maternal risk for preeclampsia |
| Q92980466 | Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia |
| Q35714000 | Evaluation of serum β-hCG and PAPP-A levels in pregnant women at risk of developing preeclampsia |
| Q27012889 | Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency |
| Q51010638 | First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies. |
| Q48008304 | First-trimester hyperglycosylated human chorionic gonadotropin and development of hypertension |
| Q39813910 | Impact of maternal serum levels of Visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11-13 weeks gestation on small for gestational age births |
| Q53344481 | Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester. |
| Q50638104 | Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers. |
Search more.